KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Accounts Payables (2016 - 2025)

Astrana Health (ASTH) has disclosed Accounts Payables for 15 consecutive years, with $195.9 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 84.58% to $195.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195.9 million through Dec 2025, up 84.58% year-over-year, with the annual reading at $195.9 million for FY2025, 84.58% up from the prior year.
  • Accounts Payables hit $195.9 million in Q4 2025 for Astrana Health, down from $209.7 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $209.7 million in Q3 2025 to a low of $11.2 million in Q2 2021.
  • Historically, Accounts Payables has averaged $76.9 million across 5 years, with a median of $51.5 million in 2023.
  • Biggest YoY gain for Accounts Payables was 500.95% in 2021; the steepest drop was 54.85% in 2021.
  • Year by year, Accounts Payables stood at $44.0 million in 2021, then rose by 12.77% to $49.6 million in 2022, then grew by 20.96% to $59.9 million in 2023, then skyrocketed by 77.05% to $106.1 million in 2024, then surged by 84.58% to $195.9 million in 2025.
  • Business Quant data shows Accounts Payables for ASTH at $195.9 million in Q4 2025, $209.7 million in Q3 2025, and $119.7 million in Q2 2025.